A team at Bar-Ilan University’s Sagol Center maps acetylation sites across 107 mammalian species and uses computational analyses to link specific protein modifications with extended lifespan, suggesting targeted acetylation mimics could counter age-related damage.
Key points
Comparative acetylome profiling across 107 mammals identifies ~300 lifespan-linked acetylation sites.
PHARAOH computational analysis correlates specific acetyl modifications with DNA repair, metabolism, and stress pathways.
Experimental mice models with humanized acetylation sites to assess effects on lifespan and healthspan.
Why it matters:
Decoding evolutionary acetylation patterns reveals tunable mechanisms for lifespan extension, paving the way for novel anti-aging therapies.
Q&A
What is protein acetylation?
How does the PHARAOH tool work?
Why compare different mammals?
What are potential therapies targeting acetylation?
Protein acetylation is a reversible chemical modification that adds an acetyl group to specific amino acids in proteins. This process plays critical roles in regulating cellular functions such as gene expression, metabolism, and DNA repair. Growing evidence links acetylation patterns to aging and lifespan, making it a central topic in longevity research.
Protein acetylation typically occurs on lysine residues via the action of two enzyme families: acetyltransferases (which add acetyl groups) and deacetylases (which remove them). By neutralizing the positive charge on lysine, acetylation can alter protein folding, stability, interaction partners, and subcellular localization.
Comparative studies of multiple mammalian species reveal that long-lived animals often evolve unique acetylation patterns on proteins involved in stress resistance and cellular maintenance. For example, some acetylation sites become fixed to ensure continuous protection, while others remain flexible to adapt to environmental changes. These evolutionary adaptations suggest that specific acetylation profiles can optimize longevity.
Understanding protein acetylation’s role in longevity bridges evolutionary biology and translational medicine. Ongoing research aims to harness acetylation modifications for targeted interventions that delay age-related diseases and extend healthy human lifespan.